find out how groundbreaking investigation is turning "undruggable" targets into therapeutic options. tales such as this afraid Smith. He took Etizolam when he was 21 and looking for any new higher. At enough time, he'd been working with drugs due to the fact he was 15. Etizolam is a certain antagonist at PAFR. It inhibits PAF-induced platelet